Efficacy of venetoclax-dexamethasone (VenDex) v pomalidomide-dexamethasone (PomDex) in patients (Pts) with t(11;14)-positive relapsed/refractory multiple myeloma [t(11;14)+ RRMM]: Phase 3 CANOVA study ...

(UroToday.com) The 2024 American Society of Clinical Oncology (ASCO) annual meeting featured a session on prostate cancer, and a presentation by Dr. Daniel Petrylak discussing initial results of a ...

Feb. 10—TRENTON — Aivaye Ingram dropped 31 points, Juan Sanchez poured in 21, and the Trenton boys basketball team took care of business with an 84-43 win against WW-P South on Tuesday in the first ...

Phonemic awareness is one of those skill areas that shows up everywhere in early literacy discussions, but often with very little explanation about how it should be addressed inside an IEP. By the ...

AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...

Host Rewa secured a narrow 1–0 victory over Labasa in the first leg of the Pillay Garments Champion vs Champion match at Ratu Cakobau Park in Nausori this afternoon. The visitors took the lead early, ...

GM1 gangliosidosis, caused by biallelic variants in GLB1, results from deficiency of lysosomal β-galactosidase, which degrades GM1 ganglioside. This fatal neurodegenerative disease currently has no ...

It’s all set up for the Lawrence boys basketball team to get redemption. After falling short in last year’s CVC Tournament championship game, the Cardinals (15-6) secured the No. 1 seed in this year’s ...

Ocular Therapeutix (OCUL) is a Strong Buy, driven by the pivotal SOL-1 Phase 3 trial for AXPAXLI™ in wet AMD, with topline results expected Q1 2026. AXPAXLI™ leverages proven science and a de-risked ...

SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Neomorph, Inc., a biotechnology company pioneering molecular glue degraders to address previously undruggable proteins, today announced the first patient ...